Breakthrough Treatment For Obstructive Sleep Apnea Now Offered

Obstructive sleep apnea (OSA) patients understand how challenging it is to manage their condition effectively. Along with the significant health consequences of Obstructive Sleep Apnea, such as high blood pressure, increased stroke risk, and weight gain, extreme daytime drowsiness, mood swings, and loud snoring are also unpleasant.

Today, this condition affects over 18 million Americans. Although the Continuous Positive Airway Pressure (CPAP) machine is a frequently utilised therapy tool, studies show that about 50% of patients eventually cease using it. Fortunately, Boston Medical Center patients have an alternative way to control their Obstructive Sleep Apnea. 

Can’t use CPAP? Try the FDA-approved, ground-breaking therapy known as Inspire® therapy. This implantable, minimally invasive gadget stimulates the tongue muscle’s nerves, maintaining the airway as you sleep.

The implanted gadget is about the same size as a quarter and is placed just below the chest skin. Most patients return home immediately after the quick and easy treatment. The patient activates Inspire® with a tiny remote when they go to bed, and their breath is tracked the whole time they sleep.

Use The Inspire® Therapy If You:

  • Have a moderate-severe obstructed breathing pattern
  • Can’t utilise or profit from CPAP regularly
  • Are you 22 years or older and not very obese

New Obstructive Sleep Apnea Treatment

Oral Appliance Therapy

Oral appliance therapy has developed as a separate alternative treatment strategy to address obstructive sleep apnea since 2010. The use of oral appliance therapy is advised for PAP intolerant patients or those looking for alternatives to PAP therapy, according to the treatment protocols for the therapeutic interventions published by Obstructive Sleep Apnea research institutions such as the American Academy of Dental Sleep in 2015.

Upper Airway Stimulation Therapy

The surgical environment for treating Obstructive Sleep Apnea has evolved recently: upper airway stimulation therapy was authorised by a government administration in the U.S. in 2014 to rehabilitate PAP-intolerant patients suffering from Obstructive Sleep Apnea. Due to this therapy, many patients unable to endure conventional surgical modalities like jaw advancement or soft tissue surgery now have more treatment alternatives.

Multidisciplinary Pap-Intolerance Clinic Planned

Mayo Clinic Pulmonary & Critical Care Medicine is developing an interdisciplinary PAP-intolerance treatment centre. In this treatment centre, a team of dental sleep specialists, sleep surgeons, and a doctor will work together to give PAP intolerant patients a comprehensive assessment and interactive care regimen to provide the most suitable individualised care plan.

Share Link :